Sep 15, 2016 11:45 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced that the first...
Sep 15, 2016 11:30 am UTC| Business
BRUSSELS, Belgium, Sept. 15, 2016 -- WABCO Holdings Inc. (NYSE:WBC) (www.wabco-auto.com), a leading global supplier of technologies that improve the safety, efficiency and connectivity of commercial vehicles, today...
Sep 15, 2016 11:30 am UTC| Business
SAN DIEGO, Sept. 15, 2016 -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today...
Sep 15, 2016 11:30 am UTC| Business
$21 Million in Private Placements, Funded in Two Tranches, Including $5 Million fromSanford Health to Support Type 1 Diabetes Candidate Development $4 Million in a Registered Direct Offering to an Existing Institutional...
Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
Sep 15, 2016 11:05 am UTC| Business
CAMBRIDGE, Mass., Sept. 15, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
2017 TAG Cyber Security Annual Names Imperva a Distinguished Vendor
Sep 15, 2016 11:03 am UTC| Business
REDWOOD SHORES, Calif., Sept. 15, 2016 -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced it was named a distinguished vendor by...
NetSol Technologies Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results
Sep 15, 2016 11:01 am UTC| Business
Total Net Revenues Increased 24% Year-over-Year for the Fourth Quarter and 26% for the Full Fiscal Year 2016GAAP Diluted EPS of $0.19 for the Fourth Quarter and $0.32 for the Full Fiscal Year 2016Adjusted EBITDA of $4.1...